FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 160 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $384,000 | -33.8% | 10,625 | -8.2% | 0.01% | -28.6% |
| Q4 2016 | $580,000 | -55.0% | 11,575 | -52.9% | 0.01% | -53.3% |
| Q3 2016 | $1,290,000 | -65.5% | 24,575 | -72.8% | 0.02% | -34.8% |
| Q2 2016 | $3,736,000 | +99.1% | 90,350 | +95.7% | 0.02% | -8.0% |
| Q1 2016 | $1,876,000 | -1.1% | 46,175 | +1.1% | 0.02% | -3.8% |
| Q4 2015 | $1,896,000 | +222.4% | 45,675 | +19.6% | 0.03% | +225.0% |
| Q3 2015 | $588,000 | -37.2% | 38,175 | +1.3% | 0.01% | -27.3% |
| Q2 2015 | $936,000 | +57.6% | 37,675 | +44.9% | 0.01% | +57.1% |
| Q1 2015 | $594,000 | +66.4% | 26,000 | +96.6% | 0.01% | +75.0% |
| Q4 2014 | $357,000 | +170.5% | 13,225 | +17.8% | 0.00% | +300.0% |
| Q3 2014 | $132,000 | -77.7% | 11,225 | -70.5% | 0.00% | -83.3% |
| Q2 2014 | $591,000 | -24.9% | 38,025 | -5.0% | 0.01% | -40.0% |
| Q1 2014 | $787,000 | – | 40,025 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|